PharmiWeb.com - Global Pharma News & Resources
04-Jan-2019

Worldwide Antifungal Drugs Market (2018-2022) to Register a CAGR of Over 3% - Astellas Pharma, Basilea Pharmaceutica, Merck and Pfizer are the Dominant Vendors - ResearchAndMarkets.com

The "Global Antifungal Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The antifungal drugs market is projected to register a CAGR of over 3% by 2022.

Use of antifungal infections is expected to drive growth in the market

Research has shown synergism between many antifungals, which has led to an increase in clinicians prescribing combination therapies over monotherapies. Also, availability of antifungals with novel mechanisms of actions has promoted the trend of using combinations.

Increase in antifungal research funding

An increase in funding for antifungal research is another key factor contributing to the growth of the global antifungal drugs market. In many European countries, government funding is also available for research in fungal diseases.

Diagnostic challenges due to non-specific symptoms

Antifungals are often associated with mild adverse effects like itching, redness, abdominal pain, and diarrhea.

Key Players

  • Astellas Pharma
  • Basilea Pharmaceutica
  • Merck
  • Pfizer

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: PIPELINE ANALYSIS

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

PART 08: MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION

  • Segmentation by route of administration
  • Comparison by route of administration
  • Topical - Market size and forecast 2017-2022
  • Oral - Market size and forecast 2017-2022
  • Parenteral - Market size and forecast 2017-2022
  • Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Vendors covered

PART 15: VENDOR ANALYSIS

  • Market positioning of vendors
  • Astellas Pharma
  • Basilea Pharmaceutica
  • Merck
  • Pfizer

For more information about this report visit https://www.researchandmarkets.com/research/6x3cx8/worldwide?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190104005393/en/

Editor Details

Last Updated: 04-Jan-2019